D'ALIBERTI, DEBORAH
D'ALIBERTI, DEBORAH
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Paired Exome Sequencing Reveals Recurrent Germline Variants in Patients with Idiopathic Erythrocytosis
2019 Mauri, M; Elli, E; D'Aliberti, D; Crespiatico, I; Nava, M; Massimino, L; Sharma, G; Fontana, D; Redaelli, S; Bombelli, S; Pelucchi, S; Perego, R; Piperno, A; Gambacorti Passerini, C; Piazza, R
De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways
2019 Magistroni, V; Mauri, M; D'Aliberti, D; Mezzatesta, C; Crespiatico, I; Nava, M; Fontana, D; Sharma, N; Parker, W; Schreiber, A; Yeung, D; Pirola, A; Redaelli, S; Massimino, L; Wang, P; Khandelwal, P; Citterio, S; Viltadi, M; Bombelli, S; Rigolio, R; Perego, R; Boultwood, J; Morotti, A; Saglio, G; Dong-Wook, K; Branford, S; Gambacorti Passerini, C; Piazza, R
Decitabine treatment for an unusual case of atypical chronic myeloid leukemia (aCML) with a concomitant chronic lymphocytic leukemia (CLL)
2019 Cassin, R; Mattiello, V; Viltadi, M; D'Aliberti, D; Piazza, R; Gambacorti-Passerini, C; Gianelli, U; Neri, A; Cortelezzi, A; Reda, G
A fatal case of TEMPI syndrome, refractory to proteasome inhibitors and autologous stem cell transplantation
2020 Diral, E; Parma, M; Renso, R; Pezzatti, S; Terruzzi, E; Perfetti, P; D'Aliberti, D; Gambacorti Passerini, C; Piazza, R; Elli, E
ETNK1 mutations in atypical chronic myeloid leukemia induce a mutator phenotype that can be reverted with phosphoethanolamine
2020 Fontana, D; Mauri, M; Renso, R; Docci, M; Crespiatico, I; Rost, L; Jang, M; Niro, A; D'Aliberti, D; Massimino, L; Bertagna, M; Zambrotta, G; Bossi, M; Citterio, S; Crescenzi, B; Fanelli, F; Cassina, V; Corti, R; Salerno, D; Nardo, L; Chinello, C; Mantegazza, F; Mecucci, C; Magni, F; Cavaletti, G; Bruheim, P; Rea, D; Larsen, S; Piazza, R; Gambacorti-Passerini, C
ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine
2020 Fontana, D; Mauri, M; Renso, R; Docci, M; Crespiatico, I; Rost, L; Jang, M; Niro, A; D'Aliberti, D; Massimino, L; Bertagna, M; Zambrotta, G; Bossi, M; Citterio, S; Crescenzi, B; Fanelli, F; Cassina, V; Corti, R; Salerno, D; Nardo, L; Chinello, C; Mantegazza, F; Mecucci, C; Magni, F; Cavaletti, G; Bruheim, P; Rea, D; Larsen, S; Gambacorti-Passerini, C; Piazza, R
Characterization of the transcriptional landscape of atypical Chronic Myeloid Leukemia at single-cell resolution
2022 Fontana, D; Crippa, V; Bassi, G; D'Aliberti, D; Mauri, M; Spinelli, S; Mastini, C; Bombelli, S; Civettini, I; Guglielmana, V; Perego, R; Ramazzotti, D; Mologni, L; Piazza, R; Gambacorti Passerini, C
Clinical and Molecular features of the patients with Idiopathic Erythrocytosis
2022 Elli, E; Mauri, M; D’Aliberti, D; Crespiatico, I; Fontana, D; Redaelli, S; Pelucchi, S; Manghisi, B; Cavalca, F; Ripamonti, A; Brioschi, F; Palamini, S; Mottadelli, F; Ramazzotti, D; Piperno, A; Gambacorti Passerini, C; Piazza, R
Liquid Biopsy in Cancer: Focus on Lymphoproliferative Disorders
2022 Savino, F; Rigali, F; Giustini, V; D'Aliberti, D; Spinelli, S; Piazza, R; Sacco, A; Roccaro, A
Large-Scale Analysis of SARS-CoV-2 Synonymous Mutations Reveals the Adaptation to the Human Codon Usage During the Virus Evolution
2022 Ramazzotti, D; Angaroni, F; Maspero, D; Mauri, M; D’Aliberti, D; Fontana, D; Antoniotti, M; Elli, E; Graudenzi, A; Piazza, R
Targeting CCR7-PI3Kγ overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphoma
2023 Mastini, C; Campisi, M; Patrucco, E; Mura, G; Ferreira, A; Costa, C; Ambrogio, C; Germena, G; Martinengo, C; Peola, S; Mota, I; Vissio, E; Molinaro, L; Arigoni, M; Olivero, M; Calogero, R; Prokoph, N; Tabbò, F; Shoji, B; Brugieres, L; Geoerger, B; Turner, S; Cuesta-Mateos, C; D’Aliberti, D; Mologni, L; Piazza, R; Gambacorti Passerini, C; Inghirami, G; Chiono, V; Kamm, R; Hirsch, E; Koch, R; Weinstock, D; Aster, J; Voena, C; Chiarle, R
Balanced SET levels favor the correct enhancer repertoire during cell fate acquisition
2023 Zaghi, M; Banfi, F; Massimino, L; Volpin, M; Bellini, E; Brusco, S; Merelli, I; Barone, C; Bruni, M; Bossini, L; Lamparelli, L; Pintado, L; D'Aliberti, D; Spinelli, S; Mologni, L; Colasante, G; Ungaro, F; Cioni, J; Azzoni, E; Piazza, R; Montini, E; Broccoli, V; Sessa, A
Characterization of SARS-CoV-2 Mutational Signatures from 1.5+ Million Raw Sequencing Samples
2023 Aroldi, A; Angaroni, F; D’Aliberti, D; Spinelli, S; Crespiatico, I; Crippa, V; Piazza, R; Graudenzi, A; Ramazzotti, D
Targeting the immune microenvironment in Waldenström Macroglobulinemia via halting the CD40/CD40-ligand axis
2023 Sacco, A; Desantis, V; Celay, J; Giustini, V; Rigali, F; Savino, F; Cea, M; Soncini, D; Cagnetta, A; Solimando, A; D'Aliberti, D; Spinelli, S; Ramazzotti, D; Almici, C; Todoerti, K; Neri, A; Anastasia, A; Tucci, A; Motta, M; Chiarini, M; Kawano, Y; Martinez-Climent, J; Piazza, R; Roccaro, A
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis
2024 Crespiatico, I; Zaghi, M; Mastini, C; D'Aliberti, D; Mauri, M; Mercado, C; Fontana, D; Spinelli, S; Crippa, V; Inzoli, E; Manghisi, B; Civettini, I; Ramazzotti, D; Sangiorgio, V; Gengotti, M; Brambilla, V; Aroldi, A; Banfi, F; Barone, C; Orsenigo, R; Riera, L; Riminucci, M; Corsi, A; Breccia, M; Morotti, A; Cilloni, D; Roccaro, A; Sacco, A; Stagno, F; Serafini, M; Mottadelli, F; Cazzaniga, G; Pagni, F; Chiarle, R; Azzoni, E; Sessa, A; Gambacorti Passerini, C; Elli, E; Mologni, L; Piazza, R
Idiopathic erythrocytosis: a germline disease?
2024 Elli, E; Mauri, M; D’Aliberti, D; Crespiatico, I; Fontana, D; Redaelli, S; Pelucchi, S; Spinelli, S; Manghisi, B; Cavalca, F; Aroldi, A; Ripamonti, A; Ferrari, S; Palamini, S; Mottadelli, F; Massimino, L; Ramazzotti, D; Cazzaniga, G; Piperno, A; Gambacorti-Passerini, C; Piazza, R